세계의 물리치료 장비 시장 : 제품, 용도, 최종 사용자 및 지역별 -예측(-2029년)

The physiotherapy equipment market is projected to reach USD 27.03 billion by 2029 from USD 20.13 billion in 2024, at a CAGR of 6.1 % during the forecast period. Lifestyle factors, such as lack of exercise and poor dieting, compounded by an ageing population, explain the growth of chronic illnesses like arthritis and cardiovascular diseases. The rehabilitation requirements increase correspondingly. Concomitantly, the increased number of rehabilitation requirements leads to an upsurge in demands for physiotherapy equipment in the management of older people in terms of mobility and pain relief. The market is also driven by several other factors such as rise in technological advancements, rising R&D spending, increased awareness, the need for personalised physiotherapy equipments and expansion in economy of emerging countries.

"The electrotherapy segment from the physiotherapy equipment segment accounted for the largest share during the forecast period."

Types of electrotherapy used in physiotherapy include TENS (Transcutaneous Electrical Nerve Stimulation), IFT (Interferential Therapy), EMS (Electrical Muscle Stimulation), PENS (Percutaneous Electrical Nerve Stimulation), and Therapeutic Ultrasound. Electrotherapy offers a range of non-invasive treatments that may generate significant relief from body pain and nerve pain, acceleration of healing in musculoskeletal injuries, improvement of blood circulation, wound healing, and muscle spasm relaxation-all with a minimum to no side effect. Moreover, the ease with which patients can now receive treatments has been greatly increased by the introduction of compact and portable electrotherapy devices. Additionally, the treatment outcomes of patients have improved due to enabling of patients to receive personalised care.

"The Musculoskeletal applications segment accounted for the largest share, by application during the forecast period.

Musculoskeletal physiotherapy can treat injuries such as ligament sprains, muscle strains, arthritis, cartilage tears, and support pre/post-surgery and fracture rehabilitation, as well as back pain. Factors that might explain the increase in musculoskeletal injuries include ageing and greater participation in physical activity and sports, sedentary lifestyles that contribute to poor posture and weak muscles, obesity, as well as repetitive strain from particular jobs or activities and an increasingly common incidence of chronic conditions like arthritis. The incidence of these injuries has also been exacerbated by an increase in road accidents and industrial injuries, particularly in industries that require physical labour.

"North America accounted for the largest share, by region and APAC is estimated to register the highest CAGR during the forecast period."

The physiotherapy equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa, and the GCC Countries. North America had largest share in the physiotherapy equipment market for a number of key considerations. Its advanced healthcare system, compounded by a robust reimbursement system such as Medicare, supports the deployment of advanced physiotherapy equipment for the population. Robust regulatory systems in the US facilitate the development and introduction of high-quality physiotherapy equipment, ensuring that these devices meet stringent safety and efficacy standards for optimal patient care.

The Asia Pacific is witnessed to have the highest CAGR during the forecast period. Many APAC countries, including Japan, South Korea, and China, are witnessing rapid aging in their population. Also, there is increased healthcare expenditure in rising economies such as India, Thailand and Malaysia. Therefore, high population with rising chronic illnesses and increased spending on health are the reasons for its high growth.

A breakdown of the primary participants (supply-side) for the Physiotherapy equipment market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-20%, Director Level-35%, and Others-45%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, ROW- 8% .

The prominent players in the Physiotherapy Equipment market are Enovis Corp. (US), BTL Industries (UK), Performance Health (US), ITO Co., Ltd. (Japan), Enraf-Nonius B.V. (Netherlands), Dynatronics Corporation (US), Mectronic Medicale (Italy), EMS Physio Ltd. (UK), Whitehall Manufacturing (US), Zimmer MedizinSysteme GmbH (Germany), Zynex Inc, (US), Richmar (US), Life Care Systems (India), Storz Medical AG (Germany), Mettler Electronics Corp (US), Algeos (UK), Gymna (Belgium), Astar (Poland), HMS Medical Systems (India), Embitron s.r.o (Czech Republic), Physiomed Elektromedizin AG (Germany), Tecnobody (Italy), Johari Digitals (India), PowerMedic (Denmark), and CoolSystems Inc. (US).

Research Coverage

This report studies the Physiotherapy Equipment Market based on products, applications, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Physiotherapy Equipment Market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (rapid aging, technological advancements), restraints (unstable reimbursement scenario), challenges (alternate therapies), and opportunities (rise in home healthcare services) contributing to the growth of the Physiotherapy Equipment Market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Physiotherapy Equipment Market.
• Market Development: Comprehensive information on the lucrative emerging markets by products, applications, end-users and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Physiotherapy Equipment Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Physiotherapy Equipment Market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 INCLUSIONS AND EXCLUSIONS
  • 1.3.2 MARKETS COVERED
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHYSIOTHERAPY EQUIPMENT MARKET
• 4.2 ASIA PACIFIC: PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER AND COUNTRY
• 4.3 PHYSIOTHERAPY EQUIPMENT MARKET, BY KEY COUNTRIES
• 4.4 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION
• 4.5 PHYSIOTHERAPY EQUIPMENT MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rapidly growing geriatric population and increasing instances of chronic diseases
    • 5.2.1.2 Growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular diseases
    • 5.2.1.3 Rising demand for rehabilitation care
    • 5.2.1.4 Growing demand for home-based and telerehabilitation care
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Unstable reimbursement scenario for physiotherapy
    • 5.2.2.2 Issue in direct access to physiotherapy
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Large population in emerging economies
    • 5.2.3.2 Technological advancements
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled personnel
    • 5.2.4.2 Acupuncture and other alternative therapies
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 INDUSTRY TRENDS
  • 5.4.1 INTEGRATION OF INTERNET OF THINGS IN PHYSIOTHERAPY EQUIPMENT
  • 5.4.2 TECHNOLOGICAL ADVANCEMENTS IN PHYSIOTHERAPY EQUIPMENT
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Robotic instruments
    • 5.6.1.2 Artificial intelligence and machine learning
    • 5.6.1.3 Virtual physiotherapy
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Augmented reality
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 Wearable sensors
• 5.7 REGULATORY LANDSCAPE
  • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.2 REGULATORY FRAMEWORK
    • 5.7.2.1 North America
      • 5.7.2.1.1 US
      • 5.7.2.1.2 Canada
    • 5.7.2.2 Europe
    • 5.7.2.3 Asia Pacific
      • 5.7.2.3.1 Japan
      • 5.7.2.3.2 China
      • 5.7.2.3.3 India
• 5.8 PATENT ANALYSIS
  • 5.8.1 PATENT PUBLICATION TRENDS FOR PHYSIOTHERAPY EQUIPMENT
  • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.9 TRADE ANALYSIS
• 5.10 PRICING ANALYSIS
• 5.11 KEY CONFERENCES AND EVENTS DURING 2024-2025
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 END USER EXPECTATIONS IN PHYSIOTHERAPY EQUIPMENT MARKET
• 5.14 ADJACENT MARKET ANALYSIS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 CASE STUDY 1: STARTOON LABS RECEIVED USFDA APPROVAL FOR PHEEZEE PHYSIOTHERAPY DEVICE
  • 5.16.2 CASE STUDY 2: UKNHS TO LAUNCH AI-DRIVEN PHYSIOTHERAPY CLINIC
  • 5.16.3 CASE STUDY 3: BURJEEL AND LEEJAM LAUNCHED PHYSIOTHERABIA IN RIYADH
• 5.17 SUPPLY CHAIN ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.19 INVESTMENT AND FUNDING SCENARIO
• 5.20 REIMBURSEMENT SCENARIO
• 5.21 IMPACT OF GENERATIVE AI ON PHYSIOTHERAPY EQUIPMENT MARKET

6 PHYSIOTHERAPY EQUIPMENT MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 EQUIPMENT
  • 6.2.1 ELECTROTHERAPY EQUIPMENT
    • 6.2.1.1 Neuromuscular electrical stimulation and therapeutic electrical stimulation to be used in rehabilitation settings
  • 6.2.2 ULTRASOUND EQUIPMENT
    • 6.2.2.1 Ultrasound equipment to have major applications in connective tissue therapies
  • 6.2.3 EXERCISE THERAPY EQUIPMENT
    • 6.2.3.1 Awareness of advantages of therapeutic exercises to drive segmental growth
  • 6.2.4 HEAT THERAPY EQUIPMENT
    • 6.2.4.1 Heat therapy recognized as leading treatment for arthritis
  • 6.2.5 CRYOTHERAPY EQUIPMENT
    • 6.2.5.1 Rising popularity of wellness and fitness to drive segmental growth
  • 6.2.6 COMBINATION THERAPY EQUIPMENT
    • 6.2.6.1 Wide application across different patient population to drive segmental growth
  • 6.2.7 CONTINUOUS PASSIVE MOTION THERAPY EQUIPMENT
    • 6.2.7.1 Increasing number of reconstructive joint surgeries to drive segmental growth
  • 6.2.8 SHOCKWAVE THERAPY EQUIPMENT
    • 6.2.8.1 Non-surgical therapy used to treat various indications causing acute or chronic pain
  • 6.2.9 LASER THERAPY EQUIPMENT
    • 6.2.9.1 Versatile tool used for physical therapy
  • 6.2.10 TRACTION THERAPY EQUIPMENT
    • 6.2.10.1 Growing cases of non-traumatic spinal cord injuries to drive demand
  • 6.2.11 MAGNETIC PRESSURE THERAPY EQUIPMENT
    • 6.2.11.1 Therapeutic effectiveness of magnetotherapy to be lower than other physical therapies
  • 6.2.12 OTHER PHYSIOTHERAPY EQUIPMENT
• 6.3 ACCESSORIES
  • 6.3.1 PHYSIOTHERAPY FURNITURE
    • 6.3.1.1 Used for physical therapy, rehab, occupational therapy, sports medicine, and chiropractic medicine
  • 6.3.2 OTHER ACCESSORIES

7 PHYSIOTHERAPY EQUIPMENT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 MUSCULOSKELETAL
  • 7.2.1 RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE GROWTH
• 7.3 NEUROLOGICAL
  • 7.3.1 INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO DRIVE GROWTH
• 7.4 CARDIOVASCULAR & PULMONARY
  • 7.4.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE GROWTH
• 7.5 PEDIATRIC
  • 7.5.1 PEDIATRIC PHYSIOTHERAPY TO PROMOTE ACTIVITY AND PARTICIPATION IN EVERYDAY ROUTINES
• 7.6 GYNECOLOGICAL
  • 7.6.1 GYNECOLOGICAL SEGMENT TO BE FASTEST-GROWING APPLICATION DURING FORECAST PERIOD
• 7.7 OTHER APPLICATIONS

8 PHYSIOTHERAPY EQUIPMENT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 PHYSIOTHERAPY & REHABILITATION CENTERS
  • 8.2.1 RISING INCIDENCE OF SPORTS INJURIES AND DISABILITIES TO DRIVE SEGMENTAL GROWTH
• 8.3 HOSPITALS
  • 8.3.1 GROWING PATIENT VOLUMES AT HOSPITALS TO DRIVE SEGMENTAL GROWTH
• 8.4 HOME CARE SETTINGS
  • 8.4.1 RISING DEMAND FOR HOME CARE TO DRIVE SEGMENTAL GROWTH
• 8.5 PHYSICIANS' OFFICES
  • 8.5.1 FIRST POINT OF CONTACT FOR MANAGEMENT OF HEALTH PROBLEMS
• 8.6 OTHER END USERS

9 PHYSIOTHERAPY EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 To dominate North American market during forecast period
  • 9.2.3 CANADA
    • 9.2.3.1 Growing penetration of preventive care services to boost market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK
  • 9.3.2 GERMANY
    • 9.3.2.1 Rising geriatric population and increase in chronic conditions to drive demand
  • 9.3.3 UK
    • 9.3.3.1 Wide acceptance of physical therapy to increase adoption of physiotherapy equipment
  • 9.3.4 FRANCE
    • 9.3.4.1 Rising healthcare expenditure and favorable reimbursement scenario to drive market
  • 9.3.5 ITALY
    • 9.3.5.1 Increasing incidence of fall injuries and orthopedic disorders to drive market
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising geriatric population to drive adoption of physiotherapy equipment
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK
  • 9.4.2 JAPAN
    • 9.4.2.1 Large geriatric population to drive adoption of physiotherapy equipment
  • 9.4.3 CHINA
    • 9.4.3.1 Fitness plans by government to drive market
  • 9.4.4 INDIA
    • 9.4.4.1 Expansion of new acute care settings to drive demand
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Growing population and rising cases of chronic musculoskeletal conditions to drive market
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Fast-growing aging population and rising medical tourism to drive market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rapidly aging population and expanding healthcare infrastructure to augment market growth
  • 9.5.3 MEXICO
    • 9.5.3.1 High prevalence rates of chronic conditions to drive market
  • 9.5.4 ARGENTINA
    • 9.5.4.1 Advancements in healthcare infrastructure to drive market
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 ROBUST HEALTHCARE INDUSTRY TO DRIVE MARKET
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
• 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Region footprint
    • 10.5.5.3 Product footprint
    • 10.5.5.4 Application footprint
    • 10.5.5.5 End user footprint
• 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
• 10.7 COMPETITIVE SCENARIO
  • 10.7.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.7.2 DEALS
  • 10.7.3 EXPANSIONS
  • 10.7.4 OTHER DEVELOPMENTS
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 R&D ASSESSMENT OF KEY PLAYERS
• 10.10 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.10.1 FINANCIAL METRICS
  • 10.10.2 COMPANY VALUATION

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ENOVIS (FORMERLY COLFAX)
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
      • 11.1.1.3.4 Other developments
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 ZIMMER MEDIZINSYSTEME GMBH
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Other developments
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 ZYNEX, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches and approvals
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
      • 11.1.3.3.4 Other developments
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 PERFORMANCE HEALTH (SUBSIDIARY OF MADISON DEARBORN PARTNERS)
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Other developments
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 ITO CO., LTD.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 MnM view
      • 11.1.5.3.1 Right to win
      • 11.1.5.3.2 Strategic choices
      • 11.1.5.3.3 Weaknesses & competitive threats
  • 11.1.6 DYNATRONICS CORPORATION
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
  • 11.1.7 BTL INDUSTRIES
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
      • 11.1.7.3.2 Expansions
      • 11.1.7.3.3 Other developments
  • 11.1.8 ENRAF-NONIUS B.V.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 EMS PHYSIO LTD.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 MECTRONIC MEDICALE
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 WHITEHALL MANUFACTURING
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 RICHMAR (SUBSIDIARY OF COMPASS HEALTH BRANDS)
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Product launches
      • 11.1.12.3.2 Deals
  • 11.1.13 LIFE CARE SYSTEMS
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 STORZ MEDICAL AG
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches
      • 11.1.14.3.2 Deals
      • 11.1.14.3.3 Expansions
  • 11.1.15 METTLER ELECTRONICS CORP.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
  • 11.1.16 ALGEOS
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Deals
  • 11.1.17 GYMNA INTERNATIONAL
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Product launches
  • 11.1.18 HMS MEDICAL SYSTEMS
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Product launches
  • 11.1.19 ASTAR
    • 11.1.19.1 Business overview
    • 11.1.19.2 Products offered
  • 11.1.20 EMBITRON S.R.O. (A CERTICON GROUP COMPANY)
    • 11.1.20.1 Business overview
    • 11.1.20.2 Products offered
    • 11.1.20.3 Recent developments
      • 11.1.20.3.1 Other developments
• 11.2 OTHER PLAYERS
  • 11.2.1 PHYSIOMED ELEKTROMEDIZIN AG (FORMERLY PROXOMED)
  • 11.2.2 TECNOBODY
  • 11.2.3 COOLSYSTEMS, INC.
  • 11.2.4 JOHARI DIGITAL
  • 11.2.5 POWERMEDIC

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS